Topic 022 - technological development and validation of remote measures foruse in clinical trials in individuals with rare diseases

Ended Definitive Contract Awarded

Contract number
75N95022C00040
Awardee
Awarding agency
Obligated
$325,000

Award facts

Opportunity
Contract value 100% obligated
$325,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 7 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Newtonville, MA 02458, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

Biosensics LLC has been awarded a $325,000 firm fixed price definitive contract by the National Institutes of Health's National Center for Advancing Translational Sciences to conduct research and development activities aligned with the agency's goals. Specifically, the contract calls for Technological Development and Validation of Remote Measures for Use in Clinical Trials in Individuals with Rare Diseases, as outlined in NIH and CDC Solicitation A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals. All work will be performed by Biosensics in Newton, Massachusetts over a 10-month period concluding in June 2023. This opportunity is set aside for total small business participation.

Quick answers

Who was awarded contract 75N95022C00040?

75N95022C00040 was awarded to Biosensics LLC by National Institute on Drug Abuse (National Institutes of Health) on September 23, 2022.

How much is contract 75N95022C00040 worth?

The government has obligated $325,000 on 75N95022C00040.

Which agency awarded contract 75N95022C00040?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022C00040, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Was contract 75N95022C00040 competed?

The extent of competition for 75N95022C00040 was full and open competition after exclusion of sources. The government received 7 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award